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Abstract Bacteria such as Staphylococcus aureus are
successful as commensal organisms or pathogens in part
because they adapt rapidly to selective pressures imparted
by the human host. Mobile genetic elements (MGEs) play a
central role in this adaptation process and are a means to
transfer genetic information (DNA) among and within
bacterial species. Importantly, MGEs encode putative vir-
ulence factors and molecules that confer resistance to
antibiotics, including the gene that confers resistance to
beta-lactam antibiotics in methicillin-resistant S. aureus
(MRSA). Inasmuch as MRSA infections are a signiﬁcant
problem worldwide and continue to emerge in epidemic
waves, there has been signiﬁcant effort to improve diag-
nostic assays and to develop new antimicrobial agents for
treatment of disease. Our understanding of S. aureus MGEs
and the molecules they encode has played an important role
toward these ends and has provided detailed insight into the
evolution of antimicrobial resistance mechanisms and
virulence.
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Introduction
Mobile genetic elements (MGEs) were ﬁrst described in
the maize genome in the late 1940s [1, 2] and are an
important means for transfer of genetic information among
prokaryotes and eukaryotes. MGEs are typically identiﬁed
as fragments of DNA that encode a variety of virulence and
resistance determinants as well as the enzymes that mediate
their own transfer and integration into new host DNA [3].
MGEs demonstrate intracellular and intercellular mobility,
and those within one particular cell are called a ‘‘mobilo-
me’’ [4]. Transfer of MGEs between cells is known as
lateral or horizontal gene transfer (HGT). HGT occurs
as prokaryote-to-prokaryote, prokaryote-to-eukaryote, and
eukaryote-to-eukaryote transfer of DNA [5, 6] (Fig. 1).
MGEs may consist of insertion sequences, transposons,
phages, plasmids, pathogenicity islands, and chromosome
cassettes. These segments of DNA are largely propagated
by vertical gene transfer, which is transmission of genetic
information from parent to progeny cell (Fig. 1).
The bacterial genome consists of core and accessory
genomes. The core genome contains all genes vital to cell
survival, such as genes encoding molecules involved in
metabolism, DNA and RNA synthesis, and replication. The
accessory gene pool represents the diversity within bacte-
rial species by encoding proteins required for adaptation of
bacteria in different ecological niches (resistance, virulence
factors, etc.). Accessory genes typically have a different
G ? C content than those in the core genome, often
because they are obtained from other species of bacteria
[7, 8]. Bacteria obtain genetic information from other cells
or the surrounding environment in three ways: (1) uptake
of free DNA from the environment (transformation), (2)
bacteriophage transduction, and (3) direct contact between
bacterial cells (conjugation).
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cells and among different species or genera is one of the
main forces that generate ‘‘step change’’ or quantum leap
evolution [7]. Extrachromosomal DNA elements such as
MGEs play a crucial role in the plasticity of the genome,
allowing bacteria to adjust readily to new environments.
Selective pressure from the environment drives enrichment
for speciﬁc genes that promote ﬁtness and survival. An
example of selective pressure is that imparted by use of
antibiotics, which promotes development or acquisition of
antibiotic resistance in bacteria. Inasmuch as S. aureus is
notorious for acquiring resistance to antibiotics, some of
which is encoded by MGEs, and also contains many
putative virulence molecules on MGEs, it is an ideal model
bacterium for the purpose of this review.
S. aureus MGEs
The genus Staphylococcus consists of Gram-positive bac-
teria that colonize human or animal skin and mucosal
membranes. Although staphylococci are a part of normal
human ﬂora and thus commensal microorganisms, they are
also opportunistic pathogens and cause a wide range of
diseases. Among staphylococci, S. aureus is the most
invasive species and an etiological agent of diverse human
and animal maladies, including skin infections, abscesses,
food poisoning, toxic shock syndrome, septicemia, endo-
carditis, and pneumonia [9–11]. S. aureus is one of the
most prominent causes of nosocomial- and community-
acquired bacterial infections worldwide [12]. Although the
basis for this cadre of diseases is multifactorial and largely
dependent on host susceptibility, heterogeneity of S. aureus
strains likely plays a role in this process. Heterogeneity
among S. aureus strains develops in part as a consequence
of its interaction with the mammalian host. Numerous
putative and proven virulence factors, genes responsible
directly for host adaptation, and toxins, are located on
S. aureus MGEs [8, 13–22]. S. aureus contains many types
of MGEs, including plasmids, transposons (Tn), insertion
sequences (IS), bacteriophages, pathogenicity islands, and
staphylococcal cassette chromosomes (Figs. 2 and 3). It is
remarkable that most genes encoded by MGEs remain
under the control of global regulators located within the
core genome.
Plasmid-encoded antibiotic resistance
Plasmids are auto-replicating DNA molecules. Staphylo-
cocci typically carry one or more plasmids per cell and
these plasmids have varied gene content. Staphylococcal
plasmids can be classiﬁed into one of the three following
groups: (1) small multicopy plasmids that are cryptic or
carry a single resistance determinant; (2) larger (15–30 kb)
low copy (4–6/cell) plasmids, which usually carry several
resistance determinants; and (3) conjugative multiresistance
plasmids [23]. Larger plasmids undergo theta replication
Fig. 1 Horizontal and vertical gene transfer
Fig. 2 Acquisition of MGEs by S. aureus. 1 Incorporation of
plasmids or plasmid elements into genomic DNA. 2 Plasmids can
be maintained as free circular DNA. 3 Suicide plasmid. 4 Transfer of
a transposon or an insertion sequence between plasmid and genomic
DNA. 5 Transfer of a transposon or an insertion sequence between
plasmids within the cell. 6 Transfer of a transposon or an insertion
sequence from genomic DNA to another plasmid
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letter theta), whereas small plasmids usually replicate by the
rolling-circle mechanism [24, 25]. As a consequence of
the limited ability of S. aureus to acquire DNA from the
environment (low natural competence) compared to bacte-
ria such as Escherichia coli or Bacillus subtilis, most of
the intercellular transfer of staphylococcal plasmids occurs
by transduction or conjugation [26]. Upon entering the
bacterial host, staphylococcal plasmids remain as free
circularized DNA or linearize and integrate into the chro-
mosome (Fig. 2).
Penicillin was the ﬁrst antibiotic mass produced for use
in humans. Although initially highly effective for treatment
of S. aureus infections, today over 90% of human S. aureus
strains are resistant to this antibiotic [27]. Penicillin resis-
tance is conferred by b-lactamase, which hydrolyzes the
b-lactam ring of penicillin thereby inactivating the antibi-
otic, and/or production of a low-afﬁnity penicillin-binding
protein (PBP2a) encoded by the mecA gene [12, 27, 28].
In S. aureus, b-lactamase is encoded by the blaZ gene and
the closely linked regulatory genes, blaI and blaR [28].
Aside from plasmid encoded b-lactamase, bla genes may
be located on transposons or within chromosomal DNA
[27, 29].
More recently, S. aureus acquired vancomycin resis-
tance elements from enterococci, resulting in the
emergence of vancomycin-resistant S. aureus (VRSA) [30,
31]. Compared with vancomycin-intermediate S. aureus
(VISA, MIC: 4–8 lg/ml), in which the mechanism of
resistance is incompletely determined [32], high-level
vancomycin resistance (that in VRSA) or VanA-mediated
resistance is better characterized [30, 33, 34].
Tn1546 encodes the vancomycin resistance gene cluster
within a conjugative plasmid. This MGE was most likely
transferred to methicillin-resistant S. aureus (MRSA) from
vancomycin-resistant enterococci (VRE) during co-infec-
tion [25, 30, 31, 35]. There are two predicted fates of the
enterococcal plasmid upon entering staphylococci. On one
hand, the enterococcal plasmid could simply be main-
tained, as occurred with strains VRSA-3, 5, and 6 [31, 36].
Alternatively, Tn1546 could be incorporated into a staph-
ylococcal plasmid (VRSA-1, 7, 8, 9, and 10; plasmid
pLW1043) in which case the original enterococcal plasmid
functions as a suicide vector [31, 36]. Transposon Tn1546
encodes the vanA operon, which consists of vanA, vanH,
vanX, vanS, vanR, vanY and vanZ [30, 38]. It is interesting
that, for the second VRSA isolate reported in the US
(VRSA-2), the van operon is located within a truncated
Tn1546 on a 120-kbp plasmid, which is an unusually large
plasmid for S. aureus [37]. vanA and vanH are responsible
for synthesis of a D-Ala-D-Lac precursor that has much
lower afﬁnity to glycopeptide antibiotics than the original
D-Ala-D-Ala. vanX encodes a dipeptidase that plays a role
in the elimination of wild-type D-Ala-D-Ala targets by
hydrolysis [39]. Expression of vancomycin resistance
genes occurs only in the presence of vancomycin, a process
mediated by a two-component signal transduction system
encoded by vanS and vanR. vanY and vanZ encode an
accessory protein that could play a role in teicoplanin
resistance [34, 40].
Fig. 3 Linear schematic of the USA300 genome (strain FPR3757)
and its major MGEs. a Genome. SCCmecIVa encodes methicillin
resistance. mSAa encodes lpl, ssl and mSAb encodes lukDE, spl, bsa.
SaPI5 encodes seq2 and sek2, uSA2USA300 encodes lukS/F-PV, and
uSA3USA300 encodes sak and chip. b Plasmids of FPR3757.
pUSA03 contains genes encoding resistance to mupirocin (ileS) and
MLSB (ermC). pUSA02 encodes resistance to tetracycline (tetK).
pUSA01 is a cryptic plasmid
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molecules involved in metabolism, staphylococcal plas-
mids encode resistance to a variety of organic and
inorganic ions, such as cadmium, mercury, arsenate, etc.,
which are highly toxic for living cells (Table 1)[ 41].
Staphylococcal plasmids may also encode toxin genes. For
example, a large 37.5-kb S. aureus plasmid, pRW001,
contains genes encoding exfoliative toxin B, bacteriocin,
and bacteriocin immunity [42]. Staphylococcal exfoliative
toxins (ETs) are associated with strains isolated from
patients with staphylococcal scaled-skin syndrome (SSSS)
or bullous impetigo [43–45]. ET isoforms A, B and D are
serine proteases that speciﬁcally cleave host desmoglein 1,
resulting in loss of cell–cell adhesion in the epidermal layer
of skin, thereby causing blister formation and exfoliation
[43, 46]. In addition to pRW001, genes encoding exfolia-
tive toxins are located on phages (uETA, uETA2, and
uETA3), a genomic island (mSAc, former etdPI), and at
least one other plasmid (pETB) (Table 2)[ 21, 42, 44, 45].
Bacteriophages and virulence
Bacteriophages (phages) or bacterial viruses seem to have
the greatest impact on staphylococcal diversity and evo-
lution. All phages are classiﬁed into one of three distinctive
groups: lytic, temperate, and chronic. Lytic phages are
members of the Myoviridae family that have been used in
phage therapy, because bacteria lyse completely during
release of progeny phages. Bacteria infected with chronic
phages release progeny into the extracellular environment
without killing the host, which allows bacteria to grow and
divide. Temperate phages, which are members of the
Siphoviridae family, form the most numerous group among
all phages. Temperate phages have the ability to lyse
bacteria after infection, but they typically form a long-term
relationship with the host cell, whereby the phage DNA
integrates into the staphylococcal genome as a prophage
[47, 48]. Phages can impact expression of virulence
determinants by either positive or negative lysogenic con-
version. Following positive lysogenic conversion, bacteria
express prophage-encoded virulence determinants. Nega-
tive lysogenic conversion occurs when there is insertional
inactivation of genes (e.g., b-hemolysin of S. aureus)b y
integration of the phage DNA into the bacterial chromo-
some [47, 49]. Although there is loss of b-hemolysin
during lysogeny, these prophages contain genes encoding
immune-modulator proteins, such as staphylokinase (Sak),
staphylococcal inhibitor of complement (SCIN), and che-
motaxis inhibitory protein of S. aureus (CHIPS) [49, 50].
Other S. aureus prophages encode virulence molecules
such as enterotoxins and Panton-Valentine leukocidin
(PVL) (Table 2). PVL belongs to a group of bi-component,
pore-forming cytolytic toxins that are speciﬁc for myeloid
cells [51].
Prophages and prophage-encoded molecules also work
in concert with other MGEs within staphylococci. For
example, prophages create mobility for some staphylo-
coccal pathogenicity islands. The most common example is
the ability of helper phage 80a to mediate excision and
transfer of SaPI1 to other staphylococci [52, 53]. Some
phages also have the ability to transfer antibiotic resistance
by transduction of plasmids or plasmid elements previously
incorporated into chromosomal DNA. Plasmid pS194 with
a chloramphenicol resistance determinant and pI258 con-
taining erythromycin resistance are transduced by phages
u11 and u11de, respectively [41].
Pathogenicity islands
Staphylococcal pathogenicity islands (SaPIs) are MGEs of
14–17 kb in size (Table 2). To date, at least 16 SaPIs have
been sequenced and SaPI1 is considered as the prototype
[53, 54]. SaPIs form a coherent family with highly con-
served core genes [53, 55]. Core genes include two open
reading frames encoding transcriptional regulatory proteins
and a region encoding intergrase, Rep protein, and ter-
minase. In addition to core genes, almost all SaPIs encode
enterotoxins or toxic shock syndrome toxin (TSST) [56].
SaPIbov2 is an exception to this rule, and instead contains
Bap adhesion protein, which plays a role in bovine chronic
mastitis infections [57, 58].
Staphylococcal pathogenicity islands are integrated in
one of six different speciﬁc sites on the chromosome (atts)
and each is always in the same orientation [53]. SaPIs can
be mobilized following infection by certain staphylococcal
bacteriophages or by induction of endogenous prophages
[59, 60], such as induced excision of SaPI1 by phage 80a
[54]. Several hypotheses to explain the origin and evolution
of SaPIs exist [56]. For example, Yarwood et al. [56]
proposed the existence of a common ancestral genetic
element—probably a prophage—for all SaPIs that then
generated diversity of islands through modular recombi-
nation events.
Genomic islands
Three families of genomic islands exist among the S.aureus
strains whose genomes have been sequenced [8, 13, 16,
61]. These genomic islands, named mSAa, mSAb, and mSAc
(Table 2), are ﬂanked by a broken transposase gene
upstream and partial restriction-modiﬁcation system (RM)
type I downstream. Given the composition of genomic
islands (remnant transposase genes and a G ? C content
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MGE Resistance determinant Antibiotic/heavy metal Mechanism of action Reference
Plasmid aadD Neomycin, kanamycin,
paromomycin, and tobramycin
Aminoglycoside adenyltransferase [100, 101]
ant40 Tobramycin Aminoglycoside nucleotidyltransferase [102]
arsRBC Arsenate, antimonite Efﬂux ATPase [21, 103, 104]
blaZ, blaI, blaR1 Penicillin (b-lactam antibiotics) b-lactamase [105, 106]
ble Bleomycin Bleomycin-binding protein prevents DNA
damage by binding bleomycin
[107, 108]
cadA,B Cadmium resistance and probably
zinc
Cadmium efﬂux ATPase [109, 110]
cadD,X Cadmium resistance Efﬂux [21, 111]
cat Chloramphenicol Chloramphenicol acetyltransferase [112, 113]
cfr Chloramphenicol, ﬂorfenicol, and
clindamycin
Methylation of 23S subunit of bacterial
ribosome
[114, 115]
dfrA, dfrK Trimethoprim Dihydrofolate reductase [101, 116]
ermB,C MLSB resistance (macrolides:
erythromycin, lincosamides:
clindamycin, streptogramin B)
Methylation of 23S subunit of bacterial
ribosome
[117, 118]
fusB Fusidic acid Ribosome protection mechanism [119, 120]
ileS-2 High-level resistance to mupirocin
(pseudomonic acid A)
Isoleucyl RNA synthetase [121, 122]
mer operon Mercury Reduction of mercury ions to elementary Hg [123]
mphBM Macrolide antibiotics Putative phosphorylase [124]
msrA Macrolide antibiotics Active efﬂux [124]
mupA High-level mupirocin resistance Novel isoleucyl RNA synthetase [122, 125]
qacA,B and smr (qacC/D) Quaternary ammonium compounds,
biocides
Drug efﬂux pump [126–128]
str Streptomycin Streptomycin adenyltransferase [113]
tetK, tetL Tetracyclines Active efﬂux of tetracycline [129–131]
vat Streptogramins type A Acetylation of the antibiotic [132]
vga Streptogramins type A, lincosamides,
and pleuromutilins
Efﬂux [101]
vgb Streptogramins type B Inactivation by virginiamycin B lyase [133]
Transposon aacA-aphD Gentamycin, kanamycin, tobramycin Antibiotic modiﬁcation by aminoglycoside
acetyltransferase and aminoglycoside
phosphotransferase
[82, 86, 90]
blaZ, blaI, blaR1 b-Lactam antibiotics Hydrolysis of b-lactam ring [134]
cadB, cadC Cadmium resistance Efﬂux [135]
ermA,B MLSB resistance (macrolides:
erythromycin, lincosamides:
clindamycin, streptogramin B)
Methylation of 23S subunit of bacterial
ribosome
[118]
fexA Florfenicol, chloramphenicol Efﬂux [114]
merA, B Respectively, inorganic and organic
mercury resistance
Ion transport [89, 136, 137]
sat4 Streptothricin Streptothricin acetyltransferase [115]
spc(ant9) Spectinomycin Spectinomycin adenyltransferase [102]
tetM Tetracycline, minocycline Protection of ribosome binding site for
tetracycline
[129, 131]
vanRSHAXYZ
a Vancomycin Production of low afﬁnity pepdydoglican
precursor with terminal D-Ala-D-Lac
[30, 31, 34, 35, 40]
SCC476 far1 Fusidic acid resistance [18]
SCCmercury mer operon Mercury Ion transport [69]
a Vancomycin resistance is encoded on the Tn1546 transposon but transferred by conjugative plasmid
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Toxin/virulence determinant
(gene)
MGE Disease/mechanism of action Reference
Adhesion protein Bap (bap) SaPIbov2 Speciﬁc adhesion to bovine
mammary mucosa
[55]
Bacteriocin (bsa) mSAb Bactericidal activity against other
bacteria
[13]
Capsular polysaccharide protein SCCcap1 Inhibits phagocytosis [75]
Chemotaxis inhibitory protein
of S. aureus (chip)
u13, utp310-3, uN315, u252B,
uNM3, uMu3A, uSa3USA300,
uSa3JH1, uSa3mw, uSa3 ms,
uSa3JH9, ubC-
USA300_TCH1516
Blocks C5a and fMLP-induced
neutrophil activation and
chemotaxis; blocks C5a and
formylated peptide receptor
[50, 138]
Epidermal cell differentiation
inhibitor B (edin-B)
mSAc (etdPI) ADP-ribosyltransferase; inhibits
morphological differentiation of
keratinocytes in vitro and
modiﬁes eukaryotic Rho
GTPase
[44]
Epidermal cell differentiation
inhibitor C (edin-C)
pETB ADP-ribosyltransferase, inhibits
morphological differentiation of
keratinocytes in vitro and
modiﬁes eukaryotic Rho
GTPase
[45]
Exfoliative toxin A (eta) uETA, uETA2, uETA3 Causes staphylococcal scalded
skin syndrome (SSSS), Ritter
disease, and bulbous impetigo in
neonates
[21, 44]
Exfoliative toxin B (etb) pETB, pRW001 Causes SSSS, Ritter disease, and
bulbous impetigo in neonates
[42, 45]
Exfoliative toxin D (etd) mSAc (etdPI) Causes SSSS, Ritter disease, and
bulbous impetigo in neonates
[44, 45]
Enterotoxin A (sea) uSa3 ms, uSa3, uSa3mw,
u252B,uNM3, uMu50A,
Super antigen (SAg), causes food
poisoning
[13]
Enterotoxin B (seb) SaPI1, SaPI3,pZA10 SAg, causes food poisoning [13, 139, 140]
Enterotoxin C (sec) SaPIbov1 SAg, causes food poisoning [13, 141]
Enterotoxin C1 (sec1) SaPI4, pZA10 SAg, causes food poisoning [13, 139]
Enterotoxin C3 (sec3) SaPIn1/m1 SAg, causes food poisoning [13]
Enterotoxin C4 (sec4) SaPImw2, SaPIm3 SAg, causes food poisoning [13]
Enterotoxin D (sed) pIB485 SAg, causes food poisoning [142]
Enterotoxin G (seg) uSa3, mSAb (SaPIn3/m3) SAg, causes food poisoning [13]
Enterotoxin I (sei) mSAb (SaPIn3/m3) SAg, causes food poisoning [13]
Enterotoxin J (sej) pIB485 SAg, causes food poisoning [143]
Enterotoxin K (sek) uSa3 ms, uSa3mw, SaPIbov1,
SaPI1, SaPI3, SaPI5
SAg, causes food poisoning [56, 144]
Enterotoxin K2 (sek2) uSa3 SAg, causes food poisoning [145]
Enterotoxin L (sel) SaPI1, SaPIbov1, SaPI3,
SaPIn1/m1, SaPI4
SAg, causes food poisoning [54, 55, 144]
Enterotoxin L2 (sel2) SaPImw2, SaPIm3, SAg, causes food poisoning [13]
Enterotoxin M (sem) mSAb (SaPIn3/m3) SAg, causes food poisoning [13]
Enterotoxin N (sen) mSAb (SaPIn3/m3) SAg, causes food poisoning [13, 146]
Enterotoxin O (seo) mSAb (SaPIn3/m3) SAg, causes food poisoning [13]
Enterotoxin P (sep) uN315, uMu50A SAg, causes food poisoning [146, 147]
Enterotoxin Q (seq) uSa3 ms, uSa3mw, SaPI1, SaPI3,
SaPI5
SAg, causes food poisoning [56]
Ferrichrome operon (fhuD) SaPI3, SaPIm4 Iron up-take [148]
a-hemolysin (hla) mSAc (etdPI) Pore-forming cytolytic toxin [149, 150]
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genomic islands were once mobile elements acquired by
HGT [62]. A complete RM type I comprises host speci-
ﬁcity determinant genes hsdR, hsdM, and hsdS, but only
hsdM and hsdS are found juxtaposed to the S. aureus
genomic islands [13, 61, 63]. Both ﬂanking DNA segments
contribute to the stability of genomic islands within the
S. aureus chromosome. A lipoprotein gene cluster (lpl) and
staphylococcal superantigen-like genes (ssl) are located on
mSAa [64]. mSAb (also known as SaPIn3/m3) encodes
bacteriocin, enterotoxins, hyaluronate lyase, and a serine
protease gene cluster [13, 18, 65]. The third staphylococcal
Table 2 continued
Toxin/virulence determinant
(gene)
MGE Disease/mechanism of action Reference
Hyaluronate lyase (hysA) mSAb Degradation of
mucopolysaccharide hyaluronic
acid
[13, 151]
Leukocidin (lukM, lukF) uPV83 Pore-forming leukocyte toxin [152]
Leukotoxin D, E (lukD, lukE) mSAb Pore-forming leukocyte toxin [13, 153]
Lipoprotein-like (lpl) mSAa Induce inﬂammatory response of
host immune system
[13, 65]
Lysophospholipase pAvX (poultry strains) Hypothetical role in virulence [99]
Pantone-Valentine leukocidin
(lukF-PV, lukS-PV)
uSa2mw, uPVL108, uSa2,
uSa2USA300, uSLT, uPVL,
uSLT-USA300_TCH1516,
utp310-1, u2958PVL
Pore-forming leukocyte toxin,
linked by epidemiology to
necrotic infections
[154–158]
Pathogenicity island protein (ear) SaPImw2; SaPI1, SaPI3, SaPI4,
SaPI5
Unknown [54]
Phenol-soluble modulin located
within SCCmec (psm-mec)
SCCmec Pro-inﬂammatory and cytolytic
activity
[159]
Phenol-soluble modulins (psmb) mSAc (etdPI) Possible pro-inﬂammatory activity [16, 160, 161]
Plasmin-sensitive surface protein
(pls)
SCCmec I Decreases the invasiveness of
MRSA strains, acts as an
adhesin
[162]
Serine protease-like protein (spl) mSAb (SaPIn3/m3) Hypothetical role in virulence [13, 163]
Staphopain A (scpA) pAvX Edematous and necrotic dermatitis
in chickens
[99, 164]
Staphylococcal inhibitor of
complement (scn)
u13, utp310-3, uN315, uSa3mw,
u252B, uNM3, uMu50A,
uSa3JH1, uSa3 ms, uSa3JH9,
uMu3A, uSa3USA300,
ubC-USA300_TCH1516
Inhibits phagocytosis of S. aureus
by human neutrophils; blocks
formation of C3b
[50, 165]
Staphylococcal superantigen-like,
SSL (former, staphylococcal
enterotoxin-like, set)
mSAa (SaPIn2/m2) Targeting elements of innate
immune response
[13, 166]
Staphylokinase (sak) uN315, uMu50A, uSa2,
uSa3mw, u6390, u13, u252B,
uNM3, uMu3A, uSa3 ms,
utp310-3, ubC-
USA300_TCH1516,
uSa3USA300 uSa3JH1,
uSa3JH9,
Proteolytic destruction of host
tissue; activates conversion of
plasminogen to plasmin; inhibits
opsonization by degradation of
IgG and C3b, promotes
resistance to defensins
[147, 167–169]
TSST-1 (tst) SaPI1, SaPI2, SaPIbov1, SaPI3,
SaPIn1/m1
Causes toxic shock syndrome
(TSS)
[46, 55, 170, 171]
Genomic islands: mSAa, mSAb, and mSAc (etdPI)
Pathogenicity islands: SaPIbov1 and SaPIbov2, SaPI1- SaPI5, SaPIn1/m1, SaPIn3/m3, SaPImw2, SaPIm3, and SaPIm4
Phages: u13, utp310-3, uN315, uSa3, uSa3mw, u252B, uNM3, uMu50A, uSa3JH1, uSa3 ms, uSa3JH9, uMu3A, uSa3USA300, ubC-
USA300_TCH1516, uETA, uETA2, uETA3, uPV83, uPVL108, uSLT, uPVL, uSLT-USA300_TCH1516, utp310-1, and u2958PVL
Plasmids: pAvX, pIB485, pZA10, pETB, and pRW001
SCC Staphylococcal cassette chromosome
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phenol-soluble modulins and a cluster of ssl genes similar
to that present within mSAa [16].
Staphylococcal cassette chromosome
Staphylococcal cassette chromosomes (SCCs) are rela-
tively large fragments of DNA that always insert into the
orfX gene on the S. aureus chromosome. SCC can encode
antibiotic resistance and/or virulence determinants. Con-
sidering that many SCCs encode the methicillin resistance
gene (mecA), SCCs can be classiﬁed into staphylococcal
cassette chromosome mec (SCCmec) or non-SCCmec
groups.
SCCmec
The ﬁrst MRSA strain was reported in 1961, 2 years after
the introduction of methicillin for treatment of penicillin-
resistant S. aureus infections [12, 66]. All MRSA strains
contain SCCmec, which encodes the mecA gene, thus
conferring resistance to methicillin and all b-lactam anti-
biotics (reviewed in [12]). SCCmec may have been
acquired by S. aureus from S. sciuri [67, 68]. Resistance to
b-lactam antibiotics is maintained by production of a low-
afﬁnity penicillin-binding protein (PBP2a), which fails to
bind methicillin and other b-lactam antibiotics. As a result,
these antibiotics do not inhibit the ability of PBPs (trans-
peptidase enzymes) to cross-link peptidoglycan polymers
of the bacterial cell wall. In addition to the mecA gene,
SCCmec encodes the repressor MecI, transmembrane
b-lactam signal transducer MecR1, recombinases CcrAB
and CcrC, and joining (formerly junkyard) regions J, which
may also encode additional antibiotic resistance (Fig. 4).
Integration and excision of SCCmec by the recombinases
occurs within a speciﬁc attachment site (attBscc) on the
S. aureus chromosome at the 30 end of orfX [61].
Based on the organization of mec and associated genes
within the SCCmec complex, ﬁve (A–E) different classes
of SCCmec have been deﬁned, of which three (A–C) are
the most common in S. aureus [69–71]. Only class A
Fig. 4 Comparison of S. aureus SCCmec types. Class A SCCmec
contains a complete mecA regulon (mec1-mecR1-mecA). Class B and
class C SCCmec contain regulatory genes that are disrupted by
IS, IS1272-DmecR1-mecA and IS431-DmecR1-mecA, respectively.
Tn554 encodes erythromycin (ermA) and streptomycin/spectinomycin
resistance (aad9 or spc); copA encodes a putative copper-transport
ATPase; hsdR, hsdM, and hsdS encode a partial restriction-modiﬁ-
cation system (RM) type I; Tn4001 encodes an aminoglycoside
resistance operon (aacA-aphD); plasmid pT181 encodes tetracycline
resistance (tet); WTn554 encodes cadmium resistance (cadB, cadC);
and plasmid pUB110 encodes bleomycin (ble) and tobramycin
resistance (ant40). pls Plasmin-sensitive surface protein
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mecR1-mecA), as the regulatory genes are disrupted by
insertional sequences in class B and C, SCCmec–IS1272-
DmecR1-mecA in class B and IS431-DmecR1-mecA in class
C SCCmec elements [61, 70]. Three classes of the mec
complex and four different ccr allotypes deﬁne at present
eight SCCmec types (I–VIII) (Fig. 4). However, SCCmec
types can be further differentiated into subtypes depending
on variations in the J regions. Interestingly, community-
associated MRSA (CA-MRSA) strains typically carry
SCCmecIV, V, or VII elements [72], whereas HA-MRSA
typically contain the larger SCCmecI, II, III, VI, or VIII
elements that may encode resistance determinants in
addition to mecA [12, 13, 69, 72]. These additional resis-
tance determinants are often encoded by plasmids,
transposons, or insertion sequences incorporated into the J
regions of SCCmec [61]. For example, the J1 region of
SCCmecVIII encodes a putative copper-transport ATPase
(copA) and the J2 region has a Tn554 transposon encoding
erythromycin (ermA) and streptomycin/spectinomycin
resistance (aad9) genes (for more details, see Table 1;
Fig. 4)[ 73, 74].
Non-mec SCC
Staphylococcal cassette chromosomes can be complex and
are thus not limited to encoding methicillin resistance.
Non-mec SCC and wSCC (without or no functional
recombinase) contain virulence or ﬁtness/survival deter-
minants. A methicillin-susceptible S. aureus strain,
MSSA476, contains a mec-like element (SCC476) that
encodes fusidic acid resistance [18]. SCCmercury encodes
resistance to mercury chloride that was probably obtained
from coagulase-negative staphylococci (CoNS) by inte-
gration of a plasmid that carried the resistance determinant
or by direct transfer of the SCCmercury element [69].
Some S. aureus strains produce capsular polysaccharide
1, which has been reported to confer resistance to phago-
cytosis [75]. The genes encoding synthesis of capsular
polysaccharide 1 are located on a special SCC element
named SCCcap1 [75]. Although SCCcapI resembles type
III of SCCmec, it is immobile because it lacks an active
ccrA homologue and the ccrB homologue contains a non-
sense mutation [75, 76].
Arginine catabolic mobile element
The arginine catabolic mobile element (ACME) was dis-
covered by sequencing the complete genome of USA300,
the most prominent CA-MRSA strain of North America
[15]. ACME encodes a complete arginine deiminase
pathway that converts L-arginine to carbon dioxide, ATP,
and ammonia. A cluster of six genes, arcRADBC (arc
locus) and opp3 (oligopeptide permease system), constitute
type I ACME present in the USA300 strain [15]. Type I
ACME is associated with speciﬁc SCCmec subtypes
(Fig. 3). It is present in clinical isolates belonging to
multilocus sequence type (MLST or ST) 8 containing
SCCmecIVa, but not in SCCmecIVb, IVc, or IVmisc [77].
An ACME variant that lacks the opp3 operon and varies
in DNA sequence has also been found in ST8 MSSA,
ST5 (USA100, SCCmecII), and ST59 (USA1000) strains
[77–79]. An ACME variant has also been detected in
MRSA ST97 strains carrying SCCmecV[ 77].
The arc cluster contained within ACME is distinct from
the other S. aureus arc cluster encoded within the core
genome [15]. ACME is adjacent to SCCmec and integrated
at the same attB site within orfX [15]. Therefore, it is likely
that the recombinases that mediate excision of SCCmec
also mobilize ACME [15, 80].
The role played by ACME in the success of USA300
remains unknown. Diep et al. suggest it enhances ﬁtness
of S. aureus, possibly by facilitating colonization and/or
hematogenous dissemination to target organs [15, 80]. On
the other hand, Montgomery et al. [81] found no signiﬁcant
difference between ACME-positive and ACME-negative
USA300strainsinaratmodelofnecrotizingpneumoniaand
a mouse model of skin infection. Further studies are needed
to better understand the importance of this interesting MGE.
Other transposable elements
Both insertion sequences (IS) and transposons (Tn) are
widely distributed among the S. aureus genome. They may
be present in a single copy or multiple copies on the
chromosome or in association with other MGEs.
Insertion sequences
Although insertion sequences (IS) can exist independently
in the S. aureus genome, they often present as pairs con-
stituting a composite transposon [82]. IS insert into various
loci and may cause changes in the expression of genes in
the core chromosome. In addition, IS inactivate genes by
direct insertion or by having a polar effect on the tran-
scription of nearby genes [83, 84]. Activation of genes
within the vicinity of an IS is usually mediated by pro-
moters carried by IS elements or by forming a hybrid
promoter with the native promoter of particular gene [85].
IS256 and IS257, in addition to constituting composite
transposons Tn4001 and Tn4003, form a hybrid promoter
for the aminoglycoside resistance operon (aacA-aphD) and
the gene encoding resistance to trimethoprim (dfrA),
respectively [82, 86, 87].
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Transposons (Tn) predominantly encode antibiotic resis-
tance genes in S. aureus (Table 1). The smaller transposons
are usually presented in multiple copies in the staphylo-
coccal genome, either inserted into the chromosome or into
MGEs, such as SCC or plasmids. This group includes
Tn554 and Tn552, which encode resistance to MLSB
antibiotics and spectinomycin or penicillinase, respectively
[41, 61, 88].
By comparison, larger transposons ([18 kbp) are pres-
ent in single copies and encode resistance to antibiotics
such as tetracycline [89], trimethoprim [87], aminoglyco-
sides [82, 90], or vancomycin [30, 31, 35].
Concluding remarks
A wide range of environmental conditions, including
interspecies competition within particular ecological niche
and antibiotic selective pressure, select for organisms that
have acquired MGEs—those that are presumably advan-
tageous for survival—by HGT. Production of antibiotics
by microorganisms is mirrored (countered) by develop-
ment of resistance to these molecules and is a naturally
occurring phenomenon. Antibiotics are toxins produced
by bacteria and fungi to compete with other micro-
organisms for a speciﬁc ecological niche. Unfortunately,
the level of antibiotic resistance among bacteria continues
to increase, consistent with the high use of antibiotics by
humans. Sub-inhibitory concentrations of antibiotics also
create an environment conducive to acquisition of resis-
tance [91].
Antibiotics that interfere with bacterial DNA replication
and induce an SOS response also induce excision and
transduction of prophages and staphylococcal pathogenic-
ity islands in the bacterial genome, resulting in high-
frequency of horizontal gene transfer [60, 92, 93].
Consequentially, this process promotes dissemination of
determinants encoding antibiotic resistance molecules and
virulence factors. MGEs can be species-speciﬁc, and,
therefore, differences exist in MGEs of S. aureus strains
that have a tropism for humans or animals [94]. Never-
theless, some S. aureus strains transmit from animals to
humans or vice versa [95–98]. Transfer of staphylococci
from one host species to another provides an additional
means to acquire new genetic material, often encoded by
MGEs [99].
In summary, although MGEs constitute only *25% of
the staphylococcal genome [8], they encode many puta-
tive virulence factors and antibiotic determinants and thus
play an important role in bacterial adaptability and
survival.
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